Engineered tissues are being used clinically for tissue repair and replacement, and are being developed as tools for drug screening and human disease modeling. Self-assembled tissues offer advantages over scaffold-based tissue engineering, such as enhanced matrix deposition, strength, and function. However, there are few available methods for fabricating 3D tissues without seeding cells on or within a supporting scaffold. Previously, we developed a system for fabricating self-assembled tissue rings by seeding cells into non-adhesive agarose wells. A polydimethylsiloxane (PDMS) negative was first cast in a machined polycarbonate mold, and then agarose was gelled in the PDMS negative to create ring-shaped cell seeding wells. However, the versatility of this approach was limited by the resolution of the tools available for machining the polycarbonate mold. Here, we demonstrate that 3D-printed plastic can be used as an alternative to machined polycarbonate for fabricating PDMS negatives. The 3D-printed mold and revised mold design is simpler to use, inexpensive to produce, and requires significantly less agarose and PDMS per cell seeding well. We have demonstrated that the resulting agarose wells can be used to create self-assembled tissue rings with customized diameters from a variety of different cell types. Rings can then be used for mechanical, functional, and histological analysis, or for fabricating larger and more complex tubular tissues.
Introduction
Cellular self-assembly approaches to fabricating tissue engineered blood vessels are an alternative to scaffold-based approaches. Selfassembled, scaffold-free tissues may have greater cell density, enhanced matrix deposition and strength, and improved biological function compared to scaffold-based tissues 1, 2, 3, 4 . However, forming 3D tissues without the use of exogenous scaffold support with specific sizes and shapes remains a challenge. Some methods fuse together layers of cell sheets to form thicker constructs, although this process can be time consuming and labor intensive 5 . Alternatively, cells can be seeded into non-adhesive molds and allowed to aggregate into spheroids, rings, and other tissue shapes 6, 7, 8 . Self-assembled tissue rings require fewer cells, shorter culture times, and less reagents than larger tubular engineered tissues, but can still be mechanically tested, examined histologically, or used for contractility and other functional testing 7, 9, 10, 11 . Because they can be rapidly fabricated and easily tested, tissue rings are ideal for screening large numbers of culture parameters, and have potential for use as disease models 11 or tools for drug screening 12 . Additionally, rings can be fused into more complex tissue structures such as blood vessels or trachea 7, 13 , and rings may fuse more completely than other shapes such as spheroids 14, 15 .
Agarose is widely used as a mold material for fabricating self-assembled tissues due to its biocompatibility, permeability, and non-cell adhesive properties. For example, Norotte et al. fabricated agarose molds from extruded rods, which enabled limited control over mold shape and required specialized equipment 15 . Tan et al. deposited alginate droplets as building units to fabricate custom hydrogel molds in various shapes (pyramid, square) 16 . However, the large diameter of the alginate spheroids (300 µm) resulted in features with low resolution. Such a low resolution may result in uneven mold surfaces that can adversely affect cell aggregation consistency. Alternatively, agarose can be cast into polymer negatives to create non-adhesive molds with smooth features and specific dimensions 6, 7, 17 .
We previously reported a system for fabricating custom annular agarose cell-seeding wells from a PDMS negative cast in a milled polycarbonate mold 7, 18 . Agarose was poured into the PDMS negative and allowed to set 7, 18 . Cells were then seeded into agarose wells, where they aggregated to form self-assembled, scaffold-free tissue rings in less than 24 h 7, 18 . PDMS negatives are autoclavable, can be reused many times, and are soft and flexible, making it easy to remove the solidified agarose wells. When this system was initially reported in Gwyther et al.
Representative Results
This system allows for the simple, customized fabrication of agarose cell seeding wells that enables cell self-assembly of ring-shaped 3D engineered tissues. 3D printing allows better resolution and greater flexibility in mold design than machining polycarbonate, where dimensions are constrained by the available tool sizes. With a high-resolution 3D printer, walls as thin as 0.254 mm can be printed, and trough dimensions are limited only by the resolution of the printer (15.2 µm resolution for these studies). Typically, CNC endmills less than 0.3 mm are not commercially available, so it is not possible to create troughs of smaller widths. Micro-milling can produce smaller features, although the equipment required may be prohibitively expensive or inaccessible to many biomedical research labs. Trough dimensions and curvature are also limited by the endmill tip shape. Additionally, features such as angled or tapered walls are not possible, and small features may break during the machining process.
CAD drawings can be easily modified to produce 3D-printed molds and PDMS negatives of customizable dimensions. Figure 3 describes the dimensions of our current 2 mm post 3D-printed molds, compared to previous design iterations. The process is inexpensive; the 2 mm, 5-ring 3D-printed mold cost 44.67 USD to 3D print, and each part can be used to create multiple PDMS negatives. To date, we have created more than 30 PDMS negatives from a single 3D-printed mold. Each negative requires 25 g of PDMS at 0.11 USD per g (2.75 USD per PDMS negative). Each PDMS negative can be cleaned with detergent, autoclaved, and re-used for up to several years, depending on frequency of use. Compared to the original design 18 , the compact 3D-printed mold uses considerably less PDMS and agarose per 2 mm tissue ring ( Figure 1E ).
Cells seeded in the equilibrated agarose wells aggregate to form tissue rings in less than 24 h. Ring dimensions depend on the dimensions of the agarose wells. Here, we demonstrated that self-assembled rat smooth muscle cell rings can be fabricated in wells with 2, 4, or 12 mm diameter posts (Figure 4) . While rings in this study were only cultured for 3 days, we have previously cultured hSMC rings for up to 2 weeks 22 , and hMSC-cartilage rings for up to 3 weeks 13 . As reported previously, rings can function as 3D in vitro models of human tissues for quantitative assessment of tissue function 11 and mechanical strength 13, 22 , and can also serve as modular building units to generate tube-shaped tissue constructs 7, 13 . Cell seeding conditions and functional attributes of tissue rings engineered from these cell types are summarized in Table 1 . 
Discussion
Here we have presented a versatile method for the rapid fabrication of self-assembled tissue rings with easily customized dimensions using 3D printing. Our method is similar to that reported in Svoronos et al. 6 , where 3D-printed honeycomb and dog-bone shaped wax molds were used to cast PDMS negatives. However, the molds have been modified to contain several unique design features. A notch (Figure 4A(1) ) provides orientation of the mold to allow each ring to be labeled and monitored individually. The central hole (Figure 4A(2) ) helps improve diffusion of medium into the wells. CAD file numbers are printed directly on the mold; therefore, PDMS negatives are each labeled with version number and post diameter ( Figure 4A3) . The tapered outer walls (Figure 3(1), 5 °) , at the top of the well troughs (Figure 3(2) , 45 °), and central hole (Figure 3(3) , 5 °) make it easier to remove PDMS negatives from the 3D-printed molds, and agarose wells are easier to remove from the PDMS negatives ( Figure 4A(2), A(4) ). We have demonstrated the versatility of this system by fabricating self-assembled ring-shaped tissues of a variety of diameters and cell types, including primary human smooth muscle cells (SMCs) 18, 22 , rat aortic SMCs 7, 23 , human mesenchymal stem cells (hMSCs) 13 , and SMCs derived from induced pluripotent stem cells (iPSCs) 11 ( Table 1) . In ongoing work, we are evaluating the formation of rings from additional cell types such as endothelial cells, and fusing cartilage rings of varying sizes for potential applications in tracheal replacement. In addition to completely cellderived constructs, we have also used this system to fabricate rings with incorporated cross-linked gelatin microspheres 13, 22 . Microspheres can be incorporated within tissue rings during self-assembly to provide additional mechanical strength, or for localized delivery of growth factors 13, 22 .
Copyright
When fabricating tissue rings, optimization of cell number may be required for different cell types. Minimum cell numbers may vary based on the size and type of cells. For example, hSMCs derived from iPSCs are seeded at 600,000 cells/ring 11 , hMSCs and primary hSMCs are seeded at 400,000 cells/ring 13, 22 , and rat aortic SMCs are seeded at 500,000 cells/ring 18 . Trough dimensions may also affect ring formation and the minimum number of cells required for ring formation 24 . For studies with human cells and 3D-printed molds, a trough width of 2 mm was used. The original polycarbonate molds had a trough width of 3.75 mm, which required 750,000 hSMCs to form a 2 mm cell ring 18 . With the reduced trough width, we were able to reduce the number of cells necessary for ring formation by 46%, to 400,000 cells per ring 25 . Quantities of cells seeded per ring are summarized in Table 1 .
When choosing a 3D-printed material, many factors need to be considered. Because PDMS is typically cured at 60 °C, the 3D-printed material must have a high enough melting temperature to avoid damage during PDMS curing. The melting temperature of the material used in this study (a proprietary material, see Table of Materials) is not available. However, when baked at 60 °C for 1 h, we observed that the material began to produce an odor. Thus, we decided to lower the curing temperature to 50 °C and increase the curing time in order to bake the PDMS without damaging the 3D-printed material. Adjustments in curing time may be necessary if molds are modified to form larger PDMS negatives. An additional curing period at 60 °C after PDMS removal from the 3D-printed molds prevents the final PDMS negative from remaining tacky, while limiting the temperature the 3D-printed mold is exposed to. Note that some materials inhibit curing of PDMS, so ensure that the selected material is compatible with PDMS. Finally, the mold material toxicity must also be considered. While the 3D-printed mold will not be in direct contact with cells, it is possible that some residue from the mold may be transferred to the PDMS negative during the curing procedure. We found that very thorough washing with detergent was sufficient to remove any residue from the PDMS negative. However, we previously observed that inadequate washing led to poor ring formation in agarose wells for the first few uses of the PDMS negative. The use of PDMS cast from other 3D-printed materials may require additional investigation to verify that detergent is sufficient to remove mold residues, including any potential leachates. Periodic testing may also be necessary, as it possible that repeated heating cycles (even to 50 °C) may damage the mold over time, and cause increases in residue after repeated use. To date, we have used a single 3D-printed mold to produce more than 30 PDMS negatives that have been used to successfully generate tissue rings.
Overall, 3D printing allows greater versatility for the fabrication of agarose molds than machining of polycarbonate. It provides a higher resolution than is possible with tooling, and mold design is not limited by the dimensions of the tools available. This allows for greater customization, and the addition of features such as tapering that may not be possible with machining. This system may be applied to fabricating self-assembled tissues in other shapes as well, in addition to rings 6, 17 . Using the ring fabrication method, we have developed tissue rings from a variety of cell types and sizes for potential applications in tracheal tissue engineering 13 , engineered blood vessels 7 , and modeling vascular diseases 11 .
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